Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse
Clinical trial NCT00335348 · COMPLETED
Trial details
- NCT number
- NCT00335348
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2012-07-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.